SCHEMBL15447

SCHEMBL15447

O=S(=O)([O-])c1nc2c(-c3ccccc3)cccc2[nH]1.[Na+]

nearest known ligand 0.45

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 12/20 0.45
▸ CNR1 P21554 1/20 0.41
▸ NPY5R Q15761 1/20 0.40
▸ DHODH Q02127 3/20 0.40
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ PIK3CB P42338 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ PARP1 P09874 1/20 0.37
▸ PLK4 O00444 1/20 0.36
▸ MAPK9 P45984 1/20 0.36
▸ LIMK1 P53667 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ AKT3 Q9Y243 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17435316 1.00 CNR2 (0.45) CNR2CNR1NPY5RDHODHPIK3CD
Potassium Ion SCHEMBL15525 0.97 CNR2 (0.45) CNR2CNR1NPY5RDHODHPIK3CD
SCHEMBL6675098 0.84 L3MBTL1 (0.55) CNR2CNR1NPY5RDHODHPIK3CD
SCHEMBL1580272 0.84 CNR2 (0.46) CNR2CNR1NPY5RDHODHPIK3CD
SCHEMBL16278 0.84 L3MBTL1 (0.55) CNR2CNR1NPY5RDHODHPIK3CD
Potassium Ion SCHEMBL5188114 0.79 CNR2 (0.41) CNR2CNR1DHODHPARP1
SCHEMBL14740152 0.77 L3MBTL1 (0.36) DHODHPARP1
SCHEMBL7056322 0.77 L3MBTL1 (0.54) CNR2CNR1DHODHPARP1
SCHEMBL15448 0.77 CYP3A4 (0.37) CYP1A2CYP3A4CYP2C9CYP2C19PARP1
Trolamine SCHEMBL8056127 0.75 L3MBTL1 (0.46) CNR2CNR1NPY5RDHODHPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250025403-A1 Film Former ELEMENTIS SPECIALTIES, INC. (US) 2025-01-23 — — US claimed
CN-117089268-A Preparation method of infrared blocking agent and PET blocking membrane thereof 江苏乾润新材料科技有限公司 2023-11-21 — — CN claimed
CN-116949435-A Electroless copper plating solution and method for preparing nano-bicrystal copper metal layer by electroless plating 台湾上村股份有限公司 2023-10-27 — — CN claimed
US-20230212090-A1 IMPROVEMENTS IN FOLIAR FERTILIZERS EVERRIS INTERNATIONAL B.V. (NL) 2023-07-06 — — US claimed
EP-4156940-A1 IMPROVEMENTS IN FOLIAR FERTILIZERS Everris International B.V. (NL) 2023-04-05 — — EP claimed
CN-115768265-A Improvement of foliar fertilizer 易乐施国际有限公司 2023-03-07 — — CN claimed
WO-2021239839-A1 IMPROVEMENTS IN FOLIAR FERTILIZERS EVERRIS INTERNATIONAL B.V. (NL) 2021-12-02 — — WO claimed
EP-3915375-A1 IMPROVEMENTS IN FOLIAR FERTILIZERS Everris International B.V. (NL) 2021-12-01 — — EP claimed
CN-112022773-A Anti-aging sunscreen cream and preparation method thereof 上海怡宝化妆品集团有限公司 2020-12-04 — — CN claimed
EP-2731582-B1 CHARGE PROVIDERS FOR A VESICULAR CARRIER SYSTEM OF A UV PROTECTION COMPOSITION FOR THE SKIN OR HAIR EVONIK SCHLUECHTERN GMBH (DE) 2019-01-30 — — EP claimed
EP-2731582-A2 CHARGE PROVIDERS FOR A VESICULAR CARRIER SYSTEM OF A UV PROTECTION COMPOSITION FOR THE SKIN OR HAIR ROVI Cosmetics International GmbH (DE) 2014-05-21 — — EP claimed
US-20140134221-A1 AGENT FOR PROVIDING POSITIVE SURFACE CHARGE ON UV PROTECTION VESICLES AIR PRODUCTS SCHLÜCHTERN GMBH (DE) 2014-05-15 — — US claimed
WO-2012156109-A2 CHARGE PROVIDERS FOR A VESICULAR CARRIER SYSTEM OF A UV PROTECTION COMPOSITION FOR THE SKIN OR HAIR ROVI COSMETICS INTERNATIONAL GMBH (DE) 2012-11-22 — — WO claimed
US-8152860-B2 Cosmetic composition for coloring hair comprising a direct hair dye and a carrier system comprising polysaccharides ROVI COSMETICS INTERNATIONAL GMBH (DE) 2012-04-10 — — US claimed
EP-2394629-A2 Cosmetic composition for colouring hair with a direct dye and a polysaccharide vehicle system ROVI Cosmetics International GmbH (DE) 2011-12-14 — — EP claimed
EP-2366374-A2 UV protection for skin or hair with a UV filter substance encapsulated in a vesicular carrier system ROVI Cosmetics International GmbH (DE) 2011-09-21 — — EP claimed
US-20110200666-A1 UV PROTECTION AGENT FOR THE SKIN OR HAIR HAVING A UV FILTER SUBSTANCE ENCAPSULATED IN A VESICULAR CARRIER SYSTEMü ROVI COSMETICS INTERNATIONAL GMBH (DE) 2011-08-18 — — US claimed
US-20060073106-A1 Novel stabilized cinnamic ester sunscreen compositions DSM IP ASSETS B.V. (NL) 2006-04-06 — — US claimed
EP-1589940-A1 NOVEL STABILIZED CINNAMIC ESTER SUNSCREEN COMPOSITIONS DSM IP Assets B.V. (NL) 2005-11-02 — — EP claimed
WO-2004069216-A1 NOVEL STABILIZED CINNAMIC ESTER SUNSCREEN COMPOSITIONS DSM IP ASSETS B.V. (CH) 2004-08-19 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200666-A1 UV PROTECTION AGENT FOR THE SKIN OR HAIR HAVING A UV FILTER SUBSTANCE ENCAPSULATED IN A VESICULAR CARRIER SYSTEMü HNRNPU, CD44, CUTA CNR2 2363/4885CNR1 2308/4885NPY5R 4198/4885
US-20140134221-A1 AGENT FOR PROVIDING POSITIVE SURFACE CHARGE ON UV PROTECTION VESICLES CD44, CD63, CTSA CNR2 2674/4885CNR1 2670/4885NPY5R 4003/4885
US-20060073106-A1 Novel stabilized cinnamic ester sunscreen compositions SUN2, NISCH, BCAS2 CNR2 3690/4885CNR1 3736/4885NPY5R 4469/4885
US-20250025403-A1 Film Former PUF60, ADH1A, ADH1C CNR2 1796/4885CNR1 2691/4885NPY5R 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback